HealthX Connect Osaka 2026

1 Jul 2026 | Osaka, Japan

ServiceUpdated on 23 June 2026

Colorectal cancer diagnostic testing

Clinical Director at CanSense Ltd

About

The CanSense IVD system measures spectral signatures from patient samples which provides a cancer risk-score as compared to a trained machine learning algorithm.

The test can be used as a research use only indication to support clinical trials in the colorectal cancer space and as a surrogate endpoint marker in novel drug trials.

Type

  • Research & Development
  • Testing & Analysis

Organisation

CanSense Ltd

Company (SME/startup) / 中小企業・スタートアップ

Swansea, United Kingdom

Similar opportunities